Evommune, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

4 reportsHistory

—≥ implied

Q3 FY25—▼−8.53%—

Q1 FY26—▲+5.62%—

May 7 '26±38.2%▲+1.87%×0.05

Q2 FY26—▲+5.23%—

quarterimplied−40%0+40%realized×

Q2 FY26—▲+5.23%—

May '26±38.2%▲+1.87%×0.05

Q1 FY26—▲+5.62%—

Q3 FY25—▼−8.53%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull2

5disclosed supplier and customer ties in SEC filingsSEC filings

+12.54%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

107managers reporting a position in the latest quarterly filings13F · Jun 30 '26

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

EVMN report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.